Encompass Health (NYSE: EHC) adds $100 million in 5.875% senior notes due 2034
Rhea-AI Filing Summary
Encompass Health Corporation completed a private issuance and sale of $100 million aggregate principal amount of 5.875% Senior Notes due 2034, guaranteed by certain subsidiaries. The notes were sold at 98.75% of principal, generating approximately $96.9 million in net proceeds after initial purchasers’ discounts and estimated expenses.
The company used the net proceeds, together with cash on hand, to repay a portion of the outstanding amounts under its revolving credit facility. These new notes are an additional issuance under the existing May 29, 2026 indenture, where $500,000,000 of identical 5.875% Senior Notes due 2034 are already outstanding. The new and existing notes form a single class under the indenture and rank pari passu.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Additional Notes principal: $100 million
Coupon rate: 5.875%
Purchase price: 98.75%
+3 more
6 metrics
Additional Notes principal
$100 million
Aggregate principal amount of new 5.875% Senior Notes due 2034
Coupon rate
5.875%
Interest rate on Senior Notes due 2034
Purchase price
98.75%
Price paid by initial purchasers as a percentage of principal
Net proceeds
approximately $96.9 million
Proceeds after discounts and estimated expenses from Additional Notes
Existing Notes principal
$500,000,000
Aggregate principal amount of existing 5.875% Senior Notes due 2034
Maturity year
2034
Maturity of both Additional and Existing Senior Notes series
Key Terms
revolving credit facility, Rule 144A, Regulation S, Indenture, +1 more
5 terms
revolving credit facility financial
"to repay a portion of the outstanding amounts under the Company’s revolving credit facility"
A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.
Rule 144A regulatory
"resold by the initial purchasers to qualified institutional buyers in reliance on Rule 144A under"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
Regulation S regulatory
"to non-U.S. persons in transactions outside the United States in reliance on Regulation S under"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
Indenture financial
"governed by the previously executed indenture, dated as of May 29, 2026"
An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.
pari passu financial
"Additional Notes and the Existing Notes are treated as a single class and rank pari passu"
An instruction that different claims, securities, or creditors are treated equally and share rights or payments on the same priority level. For investors, it means their position will be paid or have voting power alongside others in the same class rather than being favored or subordinated—think of several people standing in one bus line who all get on together rather than some cutting ahead. That parity affects expected recovery in reorganizations, dividend order, and relative risk.
FAQ
What did Encompass Health (EHC) announce regarding new debt on August 13, 2026?
Encompass Health completed a private issuance of $100 million aggregate principal amount of 5.875% Senior Notes due 2034. These notes are guaranteed by certain subsidiaries and issued under an existing indenture governing earlier 2034 notes.
How much cash did Encompass Health (EHC) receive from the new senior notes?
The company received net proceeds of approximately $96.9 million from the sale of the additional 5.875% Senior Notes. This reflects the 98.75% purchase price, less initial purchasers’ discounts and estimated offering expenses.
How will Encompass Health (EHC) use the proceeds from the $100 million notes?
Encompass Health used the net proceeds of about $96.9 million, together with cash on hand, to repay a portion of outstanding amounts under its revolving credit facility, shifting borrowings from the revolver into longer-term senior notes.
What are the key terms of Encompass Health’s new 5.875% Senior Notes due 2034?
The new securities are 5.875% Senior Notes due 2034, issued in a $100 million aggregate principal amount at 98.75% of par. They share identical terms with existing 2034 notes issued on May 29, 2026, except for issuance date and price.
How do the new Encompass Health (EHC) notes relate to the existing 2034 notes?
The additional $100 million of 5.875% Senior Notes due 2034 are a further issuance under the same indenture as the prior $500,000,000 2034 notes. Both series are treated as a single class and rank pari passu for all indenture purposes.
How were Encompass Health’s new senior notes offered and who can buy them?
The additional notes were sold in a private offering exempt from Securities Act registration. Initial purchasers will resell them to qualified institutional buyers under Rule 144A and to non-U.S. persons outside the United States under Regulation S.
AI-generated analysis. How Rhea-AI works. Not financial advice.
